Tirzepatide Weight Loss Review
bmiMD Tirzepatide Reviews 2026: Compounded GLP-1/GIP From $139 a Month
bmiMD sells compounded tirzepatide on a term ladder from $179 to $139/month and holds the same price at every dose — removing the biggest hidden cost in compounded GLP-1 pricing.
- $139–$179/mo depending on term length
- Same price at every dose — no titration upcharges
- Provider visit included · 100% refundable if ineligible
- Publishes its actual pharmacy test panel
$139–$179/mo by term
Compounded medication · best rates need a 6–12 month term — confirm flat-dose pricing
By Charly P. · Not medically reviewed
Published August 6, 2026 · Pricing last checked August 2026
- Same price at every dose
- Provider visit included
- 100% refundable if ineligible
- Publishes pharmacy test panel
bmiMD sells compounded tirzepatide — the dual GLP-1/GIP molecule — on a term ladder that runs from $179/mo month-to-month down to $139/mo on twelve months. That is competitive but not remarkable. What is remarkable is four words on the product page: same price at every dose. Dose escalation is the single biggest hidden cost in compounded GLP-1 pricing, and a provider that removes it has removed the thing most likely to blow up your budget in month four. See how it ranks in our best GLP-1 weight loss programs comparison.
bmiMD Tirzepatide at a Glance
| Medication | Compounded GLP-1/GIP (tirzepatide) |
|---|---|
| Format | At-home weekly injection |
| Price Range | $139–$179/mo depending on term length |
| Dose Pricing | Same price at every dose |
| Provider Visit | Included |
| Shipping | Free on every subscription order; expedited delivery |
| Clinician Access | 24/7, 100% online |
| Eligibility Refund | 100% refundable if not eligible for the program |
| Pharmacy Testing | Potency, sterility (USP 797), endotoxicity (USP 85), pH |
| FDA Status | Compounded — not FDA-approved |
| Rating Displayed | 4.9 average, 1,000+ reviews |
| Payment Options | Buy now, pay later available |
| Also Offered | Mood + energy, strength + cardio, anti-aging, peptides (coming soon) |
What Is bmiMD?
bmiMD is a telehealth platform giving patients access to GLP-1 treatments with clinical oversight, metabolic testing as necessary, and ongoing support from board-certified physicians.
| Weight loss | GLP-1 treatments (this review) |
|---|---|
| Also offered | Mood + energy, strength + cardio, anti-aging |
| Coming soon | Peptides |
bmiMD is already a familiar name on this site — we have reviewed its NAD+ therapy program separately. The tirzepatide offer is a different product with different economics, and it is the stronger of the two on price structure. For where it sits against the wider market, our best weight loss providers list is the fastest comparison.
bmiMD Pricing: The Term Ladder
bmiMD prices by commitment length. The longer the term, the lower the monthly rate — a standard structure, but the spread here is wide enough to matter.
| Term | Monthly rate | Cost of the full term |
|---|---|---|
| 1 month | $179/mo | $179 |
| 3 months (most flexible) | $159/mo | $477 |
| 6 months (most popular) | $149/mo | $894 |
| 12 months (best value) | $139/mo | $1,668 |
Twelve months at $139 costs $1,668 vs. $2,148 paid month-to-month — a $480/yr commitment discount, and a real bet on tolerating the medication. The $477 three-month tier is the sensible middle: enough runway for dose titration without a year of exposure.
“Same Price at Every Dose” Is the Headline Here
Compounded tirzepatide is normally titrated upward, and at many providers the price climbs with the dose — the rate quoted at 2.5mg isn't what you pay at 10mg, and buyers routinely find out in month three or four. bmiMD says the price does not move, which turns its ladder into an actual budget:
- No titration upcharge — the quoted rate holds from starting dose to maintenance dose.
- FeelGood Meds advertises $149 “starting at” — a price that can move with dose.
- Shed publishes a $239/mo twelve-month rate with no dose-tier table behind it. The flat-dose commitment is what actually differentiates bmiMD — not the $139 headline.
What bmiMD Publishes About Pharmacy Testing
Compounded medication lives or dies on the pharmacy behind it, and most platforms say nothing more specific than “state-licensed.” bmiMD publishes the actual test panel, which is unusual and worth crediting.
- ✓Potency — confirmed every 3 to 6 months to stay within ±10% of target strength
- ✓Sterility — screened for bacteria, fungi and other contaminants to USP 797 standards
- ✓Endotoxicity — checked to USP 85 limits for bacterial toxins
- ✓pH — adjusted for a smooth, irritation-free injection
- ✓Prepared in a state-licensed pharmacy, independently verified in FDA- and DEA-registered labs
bmiMD also states its ingredients come solely from FDA-licensed sources via licensed sterile compounding pharmacies. None of this makes the product FDA-approved — bmiMD says so plainly itself — but it is meaningfully more disclosure than the category norm.
Compounded Tirzepatide vs. Zepbound
| Factor | bmiMD compounded tirzepatide | Zepbound (branded) |
|---|---|---|
| FDA approval | Not FDA-approved; not evaluated by the FDA | FDA-approved for chronic weight management |
| Price at bmiMD | $139–$179/mo, flat across doses | Not sold by bmiMD |
| Dispensing | Licensed sterile compounding pharmacy | Retail pharmacy |
| Provider visit | Included in the program price | Billed separately |
bmiMD notes Zepbound is FDA-approved for chronic weight management and Ozempic is FDA-approved for type 2 diabetes but may be prescribed off-label for weight management. On the underlying molecule, direct comparative research has associated tirzepatide with greater average weight reduction than semaglutide, which is why the dual GLP-1/GIP mechanism commands a premium almost everywhere it is sold.
How the bmiMD Program Works
- 1.Complete the assessment
You answer a health questionnaire online. bmiMD states this assessment does not create a doctor-patient relationship — it is the input a clinician uses to decide whether treatment is appropriate.
- 2.Clinician review and prescribing decision
Clinical services are provided by doctor networks of US-licensed clinicians who determine eligibility from your medical history and responses. Providers retain full discretion to prescribe or decline. If you are not eligible, bmiMD advertises a 100% refund.
- 3.Delivery and ongoing support
Medication ships with expedited delivery and free shipping on subscription orders, with easy refills, 24/7 clinician access, and metabolic testing as necessary.
The refund-if-ineligible policy deserves a note. Being declined after paying a consultation fee is a common and frustrating outcome across this category, and several competitors describe their consultation fees as non-refundable once completed. bmiMD taking the opposite position removes the main financial risk of simply finding out whether you qualify.
Who bmiMD Tirzepatide Is Best For
Best fit: buyers already set on tirzepatide, comfortable with compounded medication, willing to commit to six or twelve months for a price that holds at maintenance dose — the $149 and $139 rates are competitive for a dual GLP-1/GIP product with the visit included.
- Less good fit if you want the FDA-approved product — bmiMD does not sell Zepbound, and says so.
- Less good fit if you're needle-averse or want to start on semaglutide — RxActivate publishes a semaglutide rate alongside tirzepatide, making it easier to compare the two molecules at one provider.
- Per the National Institute of Diabetes and Digestive and Kidney Diseases, these medications work best combined with a lifestyle program, and regain is likely after stopping.
bmiMD Tirzepatide Pros & Cons
Pros
- Same price at every dose — removes the biggest hidden cost in compounded GLP-1 pricing
- Term ladder from $179/mo down to $139/mo, published openly
- Provider visit included rather than billed separately
- 100% refundable if you are not eligible for the program
- Publishes its actual pharmacy test panel: potency ±10%, USP 797 sterility, USP 85 endotoxicity, pH
- Free shipping on every subscription order plus expedited delivery
- 24/7 clinician access and easy refills, entirely online
- Clear, unusually candid compliance language about compounded medication and FDA status
- Buy now, pay later available
Cons
- Compounded tirzepatide is not FDA-approved and has not been evaluated for safety, efficacy or quality
- The best rates require a six or twelve-month commitment paid ahead of knowing your tolerance
- Countdown-timer urgency ("Summer Closeout") is applied to pricing that is likely to recur
- No branded Zepbound option for patients who require the FDA-approved product
- Tirzepatide only in this program — no semaglutide tier to step down to on price
- The 4.9 rating and 1,000+ review count are displayed without naming the review platform
- Clinical services run through third-party doctor networks rather than in-house clinicians
How We Scored bmiMD Tirzepatide
Our 8.6/10 is a weighted mean of six categories, scored in August 2026 using the same criteria we apply to every GLP-1 program. Where we could not verify a claim, the category is capped rather than given full marks.
How We Scored It
Openly published term ladder plus flat-dose pricing you can actually budget against.
US-licensed doctor networks, refund if ineligible, and a published pharmacy test panel; medication is compounded and not FDA-approved.
Provider visit included, 24/7 clinician access, and free shipping on subscription orders.
Unusually candid disclosures; the displayed 4.9 rating is shown without naming the review platform.
100% online, weekly self-injection, expedited delivery, buy-now-pay-later.
Multi-program platform; compounded tirzepatide sits in a narrowing regulatory lane.
The same weighted method is applied to every provider we score, so competitor ratings are comparable. See our full methodology.
Bottom Line
Our Editorial Take
Most GLP-1 platforms compete on the entry price and quietly recover margin at the maintenance dose. bmiMD has given that up, and flat-dose pricing plus an included provider visit makes its ladder one of the few in this category you can actually plan against. Publishing the pharmacy test panel — potency tolerance, USP 797, USP 85 — points the same way: this is a company willing to be specific where specificity can be checked.
The friction is the sales layer around it. A countdown clock on a seasonal promotion, a 4.9 rating with no platform named, and best pricing gated behind six or twelve months paid up front are all pulling against the credibility the rest of the page earns. The compounded status is a genuine trade-off too, though bmiMD states it more plainly than most. Overall: 8.6/10.
One of the stronger compounded tirzepatide offers we have reviewed, on structure rather than headline price. Start on three months at $477 rather than the twelve-month rate, confirm the flat-dose pricing in writing, and step up the term once you know how you tolerate it.
Tirzepatide $139–$179/mo · same price at every dose
Start Your bmiMD Program Today →Compounded medication · confirm flat-dose pricing at checkout
bmiMD Alternatives
Comparing bmiMD against other GLP-1 programs — the closest like-for-like reviews:
- Pallas Health — an FDA-approved brand option too; a clinician can route the same intake to Zepbound or a compounded preparation.
- Pallas Health tirzepatide review
- Embody
- Enhance MD
Each sets out the real monthly rate, the first-month cost once intro discounts lapse, and whether a separate membership fee applies.
Recommended Providers
Our editorial team’s top picks for this category.
bmiMD Tirzepatide: Frequently Asked Questions
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.